Filing Flows › China Pharma Holdings (CPHI) › Q1 2026 › vs Q1 2025
China Pharma Holdings (CPHI) Q1 2026 vs Q1 2025 (year over year)
China Pharma Holdings's revenue fell $153K (-13%) from $1.1M in Q1 2025 to $984K in Q1 2026.
China Pharma Holdings, Q1 2026: revenue $984K (-13% year over year), operating margin -113.6%, net loss $1.1M, operating cash flow −$55K. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $984K | $1.1M | −$153K | -13% |
| Net loss | $1.1M | $786K | $358K | +46% |
| Costs & expenses | $2.1M | $1.9M | $205K | +11% |
| Operating costs | $2.1M | $1.9M | $206K | +11% |
| Interest & other, net | $26K | $27K | −$1K | -4% |
| Cost of revenue | $698K | $1.3M | −$574K | -45% |
| Research & development | $84K | $30K | $54K | +183% |
| Sales & marketing | $96K | $87K | $8K | +10% |
| General & admin | $1.2M | $507K | $719K | +142% |
| Operating cash sources | $1.1M | $786K | $358K | +46% |
| Depreciation & amortization | $981K | $329K | $651K | +198% |
| Working capital & other | $107K | $383K | −$275K | -72% |
| Cash used in operations | $55K | $74K | −$18K | -25% |
| Net loss absorbed | $1.1M | $786K | $358K | +46% |
Questions
How much did China Pharma Holdings's revenue grow year over year in Q1 2026?
China Pharma Holdings's revenue fell $153K (-13%) from $1.1M in Q1 2025 to $984K in Q1 2026.